Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of emergency medical services systems in the pan-Asian resuscitation outcomes study countries: Report from a literature review and survey.
Ong ME, Cho J, Ma MH, Tanaka H, Nishiuchi T, Al Sakaf O, Abdul Karim S, Khunkhlai N, Atilla R, Lin CH, Shahidah N, Lie D, Shin SD; PAROS Investigators. Ong ME, et al. Among authors: tanaka h. Emerg Med Australas. 2013 Feb;25(1):55-63. doi: 10.1111/1742-6723.12032. Epub 2012 Dec 19. Emerg Med Australas. 2013. PMID: 23379453 Review.
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.
Lee KH, Lee JS, Sugawara S, Kang JH, Kim HR, Inui N, Hida T, Yoshida T, Tanaka H, Yang CT, Inoue T, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Takahashi S, Nakagawa K. Lee KH, et al. Among authors: tanaka h. Lung Cancer. 2025 Jan 25;201:108109. doi: 10.1016/j.lungcan.2025.108109. Online ahead of print. Lung Cancer. 2025. PMID: 39893774
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N. Kikuchi H, et al. Among authors: tanaka h. Jpn J Clin Oncol. 2025 Feb 2:hyaf018. doi: 10.1093/jjco/hyaf018. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39893579
15,420 results
You have reached the last available page of results. Please see the User Guide for more information.